PHILADELPHIA, Dec. 16, 2010 /PRNewswire/ -- Premier Research Group Limited, the international pharmaceutical and medical device services company, announces the appointment of Christopher Codeanne to the position of Chief Financial Officer.
Mr. Codeanne has more than 20 years of management, operational, and finance and accounting experience. Prior to joining Premier Research, he was the Chief Operating Officer and Chief Financial Officer of Oncology Development Partners, LLC (d/b/a Oncopartners). He has also served as the Chief Financial Officer of both Averion International Corp and SCIREX Corporation. Mr. Codeanne serves as a member of the Board of Directors of Cornerstone Therapeutics Inc., a specialty pharmaceutical company.
Mr. Codeanne received an MBA with a concentration in finance from the University of Connecticut and a Bachelor of Science degree in Accounting from Fairfield University. He is a member of the American Institute of Certified Public Accountants, Connecticut Society of Certified Public Accountants and Financial Executives International.
"We are pleased to have Chris join Premier Research as our Chief Financial Officer. He is a seasoned leader with a proven track record in the industry," said Dr. Ludo Reynders, CEO. "With his skill set and experience, he will be instrumental in directing the finances of the company while facilitating our growth strategy."
About Premier Research
Premier Research is a leading global solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. With a network of skilled staff operating across North America and Europe and partnerships in Latin America, Asia, South Africa, Australia and the Middle East, Premier Research manages Phase 1-4 trials and programs.
They are leaders in clinical research for analgesia, oncology, neuros
|SOURCE Premier Research Group Limited|
Copyright©2010 PR Newswire.
All rights reserved